Crossmark

Double-blind randomized placebo-controlled multicenter clinical trial (phase IIa) on diindolylmethane’s efficacy and safety in the treatment of CIN: implications for cervical cancer prevention

Crossref DOI link: https://doi.org/10.1186/s13167-015-0048-9

Published Online: 2015-12-21

Published Print: 2015-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ashrafian, Levon

Sukhikh, Gennady

Kiselev, Vsevolod

Paltsev, Mikhail

Drukh, Vadim

Kuznetsov, Igor

Muyzhnek, Ekaterina

Apolikhina, Inna

Andrianova, Evgeniya
Funding

Funding for this research was provided by:

Ministry of Education and Science of the Russian Federation (No. 02.G25.31.0080 dated 23 May 2013)

Document is current

Any future updates will be listed below